| - Industry | - Sector | - CEO | TWSE Exchange | - ISIN |
| Taiwan Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
H2, Inc. is a health care technology company based in Taipei, Taiwan, that specializes in creating and developing a cloud-based health management platform. The company was founded in 2013 and is committed to advancing the digital health landscape, particularly in managing chronic diseases like diabetes. Their innovative approach allows patients to accurately track blood sugar levels alongside related activities effectively. This platform provides healthcare professionals with real-time access to comprehensive patient data, enhancing monitoring and oversight. By facilitating a seamless connection between patient self-management and professional care, H2, Inc. holds a significant position in the healthcare technology sector, particularly in prepackaged software solutions for chronic disease management. Their market capitalization reflects sustained growth in this rapidly evolving industry, driven by a focus on user-centric digital health tools accessible through their dedicated website, health2sync.com.
This platform is designed for individuals managing diabetes, enabling them to monitor and track their blood glucose levels effectively while logging relevant activities. The cloud-based technology ensures secure data storage and easy access from anywhere, promoting better healthcare outcomes through patient engagement.
H2, Inc. offers a user-friendly mobile application, which empowers patients to efficiently manage their blood sugar levels. The app provides tools for logging data, setting reminders, and viewing trends in real-time, thereby enhancing patient involvement in their own health care journey.
The platform equips healthcare professionals with immediate access to patients' latest blood glucose data and their activity logs. This capability enables medical practitioners to monitor health progress closely and respond proactively to any fluctuations or concerns, streamlining care delivery.
H2, Inc. has developed a smart cable that facilitates the synchronization of data from glucose meters directly to smartphones. This innovative device enhances the data collection process, allowing for the seamless transfer of information to the mobile application, ensuring that users can access their readings in one place.
The smart cable and additional tools are accessible through online retailers in Taiwan and the United States. This widespread availability makes it convenient for customers to acquire H2, Inc.'s products, contributing to broader patient outreach and support.